Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
218.42
210.47
159.70
154.89
199.14
235.28
178.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
218.42
210.47
159.70
154.89
199.14
235.28
178.16
Raw Material Cost
87.66
70.13
61.88
71.78
87.57
79.14
75.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
36.02
34.66
35.32
35.09
37.57
33.22
32.57
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.76
0.76
0.70
0.63
0.73
0.98
0.33
Selling and Distribution Expenses
62.74
64.46
59.85
54.05
70.80
60.85
59.69
Other Expenses
-2.37
-2.75
-2.54
-2.95
-2.99
-2.90
-2.68
Total Expenditure (Excl Depreciation)
163.49
142.49
132.33
132.03
166.77
145.21
141.00
Operating Profit (PBDIT) excl Other Income
54.900000000000006
68
27.400000000000002
22.9
32.400000000000006
90.1
37.2
Other Income
3.72
8.40
0.06
0.80
0.62
0.33
0.34
Operating Profit (PBDIT)
66.81
83.85
34.89
30.94
40.41
97.53
44.33
Interest
0.76
0.76
0.70
0.63
0.73
0.98
0.33
Exceptional Items
0.00
0.00
0.04
-0.10
0.00
0.00
-0.01
Gross Profit (PBDT)
130.76
140.34
97.82
83.12
111.57
156.14
102.93
Depreciation
8.16
7.47
7.47
7.28
7.43
7.14
6.82
Profit Before Tax
57.89
75.62
26.77
22.93
32.26
89.41
37.17
Tax
15.29
17.68
5.15
4.77
8.80
20.21
7.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.68
58.03
21.64
18.10
23.39
69.15
29.38
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.68
58.03
21.64
18.10
23.39
69.15
29.38
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.02
-0.02
-0.01
-0.03
0.00
-0.00
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.65
58.01
21.62
18.08
23.39
69.14
29.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Reserves
664.41
621.74
563.63
589.87
572.03
548.68
476.09
Earnings per share (EPS)
0.83
1.13
0.42
0.35
0.46
1.36
0.55
Diluted Earnings per share
0.83
1.13
0.42
0.35
0.46
1.36
0.55
Operating Profit Margin (Excl OI)
25.15%
32.3%
17.14%
14.76%
16.25%
38.28%
20.86%
Gross Profit Margin
30.24%
39.48%
21.44%
19.5%
19.93%
41.04%
24.69%
PAT Margin
19.54%
27.57%
13.55%
11.69%
11.75%
29.39%
16.49%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 9.69% vs -15.13% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 82.48% vs -54.56% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 58.54% vs -45.25% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 14.29% vs 133.33% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Laboratorios Farmaceúticos Rovi SA With
Figures in Million
Consolidate Quarterly Results
Change(EUR)
Change(%)
Net Sales
218.42
1,981.66
-1,763.24
-88.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
218.42
1,981.66
-1,763.24
-88.98%
Raw Material Cost
87.66
1,294.82
-1,207.16
-93.23%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
36.02
0.00
36.02
Power Cost
0
0
0.00
Manufacturing Expenses
0.76
159.99
-159.23
-99.52%
Selling and Distribution Expenses
62.74
275.30
-212.56
-77.21%
Other Expenses
-2.37
-2.33
-0.04
-1.72%
Total Expenditure (Excl Depreciation)
163.49
1,706.85
-1,543.36
-90.42%
Operating Profit (PBDIT) excl Other Income
54.93
274.81
-219.88
-80.01%
Other Income
3.72
0.57
3.15
552.63%
Operating Profit (PBDIT)
66.81
403.74
-336.93
-83.45%
Interest
0.76
159.99
-159.23
-99.52%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
130.76
686.84
-556.08
-80.96%
Depreciation
8.16
128.37
-120.21
-93.64%
Profit Before Tax
57.89
115.39
-57.50
-49.83%
Tax
15.29
-14.68
29.97
204.16%
Provisions and contingencies
0
0
0.00
Profit After Tax
42.68
98.25
-55.57
-56.56%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
42.68
98.25
-55.57
-56.56%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.02
27.52
-27.54
-100.07%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.65
125.77
-83.12
-66.09%
Equity Capital
0
0
0.00
Face Value
0.06
0.25
0.00
Reserves
664.41
5,271.00
-4,606.59
-87.39%
Earnings per share (EPS)
0.83
0.14
0.69
492.86%
Diluted Earnings per share
0.83
0.14
0.69
492.86%
Operating Profit Margin (Excl OI)
25.15%
13.87%
0.00
11.28%
Gross Profit Margin
30.24%
12.30%
0.00
17.94%
PAT Margin
19.54%
4.96%
0.00
14.58%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 21.84 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 3.75% vs 31.81% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 9.69% vs -15.13% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.27 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -26.38% vs 168.52% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 82.48% vs -54.56% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.31 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -16.42% vs 116.95% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 58.54% vs -45.25% in Dec 2024
Quarterly - Interest
Interest 0.08 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 14.29% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 14.29% vs 133.33% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.15%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
